我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
2
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
进行中(未招募)
1
50.0%
尚未招募
暂无批准数据
- Visby Medical raised approximately $55 million with potential to reach $65 million in funding led by Catalio Capital Management to accelerate launch of its FDA-authorized at-home Women's Sexual Health Test. - The company's diagnostic platform delivers laboratory-grade PCR results within 30 minutes through a single-use, disposable test that connects to a smartphone app for seamless telemedicine consultation. - Industry veterans Isaac Ro and Chuck Alpuche joined the board to enhance operational capabilities and manufacturing scale-up as the product launches in July 2025 through direct-to-consumer channels.